PAVmed (NASDAQ: PAVM)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.200 | -0.140 | 0.0600 | ||||
REV | 350.000K | 189.000K | -161.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of PAVmed (NASDAQ: PAVM) through any online brokerage.
Other companies in PAVmed’s space includes: NeuroPace (NASDAQ:NPCE), Sonendo (NYSE:SONX), Second Sight Medical (NASDAQ:EYES), LENSAR (NASDAQ:LNSR) and Vapotherm (NYSE:VAPO).
The latest price target for PAVmed (NASDAQ: PAVM) was reported by Cantor Fitzgerald on Tuesday, March 30, 2021. The analyst firm set a price target for 8.00 expecting PAVM to rise to within 12 months (a possible 765.61% upside). 0 analyst firms have reported ratings in the last year.
The stock price for PAVmed (NASDAQ: PAVM) is $0.9242 last updated Today at July 5, 2022, 4:11 PM UTC.
There are no upcoming dividends for PAVmed.
PAVmed’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for PAVmed.
PAVmed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.